Cymabay Therapeu - Delisted Stock
Cymabay Therapeu is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Cymabay Therapeu was actively traded.
Valuation
Financial Report 20th of May 2024
Cymabay Therapeu Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cymabay Therapeu market risk premium is the additional return an investor will receive from holding Cymabay Therapeu long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cymabay Therapeu. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cymabay Therapeu's alpha and beta are two of the key measurements used to evaluate Cymabay Therapeu's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.1225 | |||
| Jensen Alpha | 0.6466 | |||
| Total Risk Alpha | 0.3788 | |||
| Sortino Ratio | 0.3495 |
View Cymabay Therapeu Related Equities
| Risk & Return | Correlation |
Cymabay Therapeu Corporate Directors
Cymabay Therapeu corporate directors refer to members of a Cymabay Therapeu board of directors. The board of directors generally takes responsibility for the Cymabay Therapeu's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cymabay Therapeu's board members must vote for the resolution. The Cymabay Therapeu board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Caroline Loewy | Director | Profile | |
| Paul Truex | Director | Profile | |
| Robert Wills | Director | Profile | |
| Kurt Emster | Independent Director | Profile |
Still Interested in Cymabay Therapeu?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Cymabay Therapeu information on this page should be used as a complementary analysis to other Cymabay Therapeu's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |